ETV6 and prostate carcinoma: Prostate cancer cells with ETV6-knockdown are insensitive to TKIs while exogenous expression of ETV6 restores the anti-proliferative effects in the TKI-resistant RasB1 cell line, which expresses a mutated RAS oncogene [27, 28].